STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3406 by analyst upside · 2026-08-12
ACHC
Acadia Healthcare Company, Inc.
Healthcare · Market Cap $3B · P/E 0x
ANALYST PRICE TARGET
+7.4%
implied upside to consensus target
Current Price $31.1
Consensus Target $33.39
Bull Target $41.0
Bear Target $14.5
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
7
Hold
5
Sell
1
52-Week Low $11.43
52-Week High $35.83
YTD Return +117.6%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) N/A
Forward P/E 17.1x
EPS (TTM) $-12.42
PEG Ratio 1.37
Dividend Yield N/A
Revenue (TTM) $3.4B
Profit Margin -33.4%
52-WEEK RANGE
52-Week Low $11.43
52-Week High $35.83
Current Price $31.1
Bear Target $14.5
Bull Target $41.0
● Now $31.1 ● Target $33.39
TRADING DATA
Avg Volume 3.0M
YTD Return +117.6%
Analyst Count 14
Consensus Buy
Upside to Target +7.4%
Last Updated 2026-08-12

ANALYST SUMMARY

Acadia Healthcare Company, Inc. (ACHC) is currently trading at $31.1 with a Wall Street consensus price target of $33.39, implying potential upside of 7.4% over the next 12 months. 14 analysts currently cover ACHC, with a consensus rating of Buy - 57% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $41.0, while the most cautious has a target of $14.5.

ACHC operates in the Healthcare sector with a market capitalisation of $3B. The stock is up 117.6% year-to-date and is currently trading near the upper end of its 52-week range of $11.43 – $35.83.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ACHC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Jefferies ↑ Upgrade
Hold → Buy 2026-06-03 50% win rate (6 calls)
RBC Capital - Reiterated
Outperform → Outperform 2026-05-04 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-05-04 62% win rate (8 calls)
Cantor Fitzgerald - Reiterated
Neutral → Neutral 2026-05-01 40% win rate (10 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-05-01 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-04-28 Building track record
UBS - Reiterated
Buy → Buy 2026-04-17 33% win rate (6 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-03-03 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
41
out of 100
Coverage depth
21/30
Consensus clarity
13/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →